Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.77
-0.31 (-3.41%)
Sep 9, 2026, 4:00 PM EDT - Market closed
Arvinas Market Cap
Arvinas has a market cap or net worth of $573.44 million as of September 9, 2026. Its market cap has decreased by -1.63% in one year.
Market Cap
573.44M
Enterprise Value
13.54M
1-Year Change
-1.63%
Ranking
Category
Stock Price
$8.77
ChartMarket Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $573.44M, an increase of 11.10%. That is a compound annual growth rate of 1.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 573.44M | -24.72% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 656.57M |
| Valneva SE | 637.30M |
| OmniAb | 629.54M |
| Contineum Therapeutics | 628.27M |
| ProKidney | 607.67M |
| Tectonic Therapeutic | 601.14M |
| Zura Bio | 597.02M |
| Autolus Therapeutics | 596.20M |